» » Man To Man
Print Share Save

Man To Man

The ACS Man to Man program helps men cope with prostate cancer by offering community-based education and support for patients and their family members.

A core component of the program is the self-help and/or group support. Volunteers organize these free monthly meetings where speakers and participants learn and share information about prostate cancer, treatment, side effects, and how to cope with prostate cancer and its treatment. Programs services and activities vary depending on the location. Your local program may also include other services and activities such as:

  • One-on-one visits with a prostate cancer survivor
  • Community education (speaker's bureau)
  • Outreach and collaboration with health care professionals
Find a Man to Man program in your area

In addition, the American Cancer Society publishes Man to Man News for men with prostate cancer who are newly diagnosed, currently in treatment, or in recovery. This six-page newsletter is offered three times a year, free of charge. Past issues are available below.

Each edition of Man To Man News covers topics such as:

  • Prostate cancer treatment options
  • Healthy living after prostate cancer treatment
  • Survivor stories
  • Coping with side effects
  • Online resources

For more information or to locate a ACS Man to Man program in your area, contact your local American Cancer Society or call us toll-free at 1-800-227-2345.

Man To Man News Issue 1, 2013

Issue 1, 2013, includes an explanation of nutrition and physical activity guidelines for survivors, news of a study weighing the benefits and risks of PSA screening, and a description of the Healthy Living free monthly e-newsletter. Other articles address loss of appetite during treatment; examine surgery vs. observation for localized prostate cancer; and invite participants to a Society survivorship study. Each issue also features an inspirational story from a prostate cancer survivor.

Man To Man News Issue 3, 2012

Issue 3, 2012, includes an explanation of what happens if prostate cancer recurs, news of the US Preventive Services Task Force recommendation against routine prostate cancer screening, and a description of the ACS Clinical Trials Matching Service. Other articles address depression, examine robotic surgery for prostate cancer, and promote ACS CAN. Each issue also features an inspirational story from a prostate cancer survivor.

Man To Man News Issue 2, 2012

Issue 2, 2012, includes an explanation of expectant management, watchful waiting, and active surveillance; news of a study that showed vitamin E supplements increase prostate cancer risk; and a description of CancerCare Connect Education Workshops. Other articles describe the Patient Navigator Program, promote E-books from the American Cancer Society bookstore, and explain how a genetic mutation may one day help identify men who are likely to benefit from earlier or additional prostate cancer screening. Each issue also features an inspirational story from a prostate cancer survivor.

Man To Man News Issue 1, 2012

Issue 1, 2012, includes an article about managing pain, news of combination hormone therapy with radiation for early stage prostate cancer, and a description of the second edition of the American Cancer Society Complete Guide to Family Caregiving. Other articles explain what to expect after a prostatectomy, how age and health may factor into the decision about how aggressively to treat prostate cancer, and how American Cancer Society online tools can help patients find the information and support they need during cancer diagnosis and treatment. Each issue also features an inspirational story from a prostate cancer survivor.

Man To Man News Issue 3, 2011

Issue 3, 2011, includes an explanation of informed consent, news of the FDA approval for Zytiga for advanced prostate cancer, and a description of the Expert Voices blog. Other articles explain why exercise is especially beneficial for men with prostate cancer, how a gene study may help identify which prostate cancers could become deadly, and how smokers can get help to quit. Each issue also features an inspirational story from a prostate cancer survivor.

Man To Man News Issue 2, 2011

Issue 2, 2011, includes a comparison of the side effects of different prostate cancer treatments, new findings on behavioral therapy for incontinence, and information about a rare side effect linked to drugs commonly taken by men with prostate cancer. Other articles explain advance directives and why they are needed, questions to ask your doctor when you’re newly diagnosed, and the benefits of the I Can Cope series of online and in-person classes. Each issue also features an inspirational story from a prostate cancer survivor.

Man To Man News Issue 1, 2011

Issue 1, 2011, includes questions and issues men should consider when deciding which prostate cancer treatment is right for them, a discussion of the experimental approach to treatment known as focal therapy, and information on a new drug for advanced prostate cancer. Other articles highlight the importance of colorectal cancer screening for men who have been treated for prostate cancer, offer suggestions for coping with incontinence, and describe some ways to get involved in the fight against prostate cancer. Each issue also features an inspirational story from a prostate cancer survivor.

Man To Man News Issue 3, 2010

The Issue 3, 2010, feature story focuses on the benefits of exercise during and after prostate cancer treatment, and how to get started safely. Other articles in the current newsletter focus on tools and resources to help men make treatment decisions, the heart risk associated with hormone therapy, and a recently approved vaccine that fights advanced prostate cancer. Each issue also features an inspirational story from a prostate cancer survivor.

Man To Man News Issue 2, 2010

The Issue 2 2010 focuses on issues related to balancing work, life, and cancer treatment, specifically strategies for men continuing to work while undergoing treatment. Other articles in this issue deal with cancer-related stress, prostate cancer screening, and the pros and cons of robot-assisted surgery.

Man To Man News Issue 1, 2010

The feature story in Issue 1, 2010, focuses on coping with advanced prostate cancer, including weighing treatment options, protecting legal rights through advance directives, and finding support. Other articles in this issue cover common side effects of prostate cancer treatment, the difference between regular and laparoscopic prostate surgery, and emerging research into alcohol's effect on prostate cancer risk. Each issue of Man to Man News also contains the inspiring story of a man living with prostate cancer.

Man To Man News Issue 3, 2009

The Issue 3, 2009, feature story focuses on what happens after prostate cancer treatment ends, and includes information on healthy lifestyle steps survivors can take to help themselves stay well after treatment. Other articles in the current newsletter deal with making treatment choices, prostate cancer screening, an experimental vaccine for prostate cancer, and paying for health care in the event of a layoff. Each issue also features an inspirational story from a prostate cancer survivor.

Man To Man News Issue 2, 2009

The Issue 2, 2009, feature story focuses on recent research into supplements and prostate cancer, and includes information on healthy lifestyle steps survivors can take to help them stay well after diagnosis and treatment. Other articles in the current newsletter cover clinical trials, a new drug for advanced prostate cancer, and recent research into combining hormone therapy and radiation for treatment of prostate cancer.

Man To Man News Issue 1, 2009

The Issue 1, 2009, feature story focuses on attaining a healthy weight and the relationship between weight and prostate cancer. The information detailed in this story highlights the importance of a healthy lifestyle for prostate cancer survivors to help them stay well after diagnosis and treatment. Other articles in the current newsletter cover the question of PSA testing after age 75, and recent research into hormone therapy and an experimental prostate cancer drug.